205 related articles for article (PubMed ID: 26351264)
1. NADH-Cytochrome b5 Reductase 3 Promotes Colonization and Metastasis Formation and Is a Prognostic Marker of Disease-Free and Overall Survival in Estrogen Receptor-Negative Breast Cancer.
Lund RR; Leth-Larsen R; Caterino TD; Terp MG; Nissen J; Lænkholm AV; Jensen ON; Ditzel HJ
Mol Cell Proteomics; 2015 Nov; 14(11):2988-99. PubMed ID: 26351264
[TBL] [Abstract][Full Text] [Related]
2. miR-155, identified as anti-metastatic by global miRNA profiling of a metastasis model, inhibits cancer cell extravasation and colonization in vivo and causes significant signaling alterations.
Thomsen KG; Terp MG; Lund RR; Søkilde R; Elias D; Bak M; Litman T; Beck HC; Lyng MB; Ditzel HJ
Oncotarget; 2015 Oct; 6(30):29224-39. PubMed ID: 26317550
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancer.
Umar SM; Kashyap A; Kahol S; Mathur SR; Gogia A; Deo SVS; Prasad CP
Exp Cell Res; 2020 Nov; 396(1):112282. PubMed ID: 32919954
[TBL] [Abstract][Full Text] [Related]
4. miR-342-5p as a Potential Regulator of HER2 Breast Cancer Cell Growth.
Lindholm EM; Leivonen SK; Undlien E; Nebdal D; Git A; Caldas C; Børresen-Dale AL; Kleivi K
Microrna; 2019; 8(2):155-165. PubMed ID: 30520388
[TBL] [Abstract][Full Text] [Related]
5. Interplay between desmoglein2 and hypoxia controls metastasis in breast cancer.
Chang PH; Chen MC; Tsai YP; Tan GYT; Hsu PH; Jeng YM; Tsai YF; Yang MH; Hwang-Verslues WW
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33431674
[TBL] [Abstract][Full Text] [Related]
6. High expressions of LDHA and AMPK as prognostic biomarkers for breast cancer.
Huang X; Li X; Xie X; Ye F; Chen B; Song C; Tang H; Xie X
Breast; 2016 Dec; 30():39-46. PubMed ID: 27598996
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis.
Jin L; Chun J; Pan C; Alesi GN; Li D; Magliocca KR; Kang Y; Chen ZG; Shin DM; Khuri FR; Fan J; Kang S
Oncogene; 2017 Jul; 36(27):3797-3806. PubMed ID: 28218905
[TBL] [Abstract][Full Text] [Related]
8. Stable shRNA Silencing of Lactate Dehydrogenase A (LDHA) in Human MDA-MB-231 Breast Cancer Cells Fails to Alter Lactic Acid Production, Glycolytic Activity, ATP or Survival.
Mack N; Mazzio EA; Bauer D; Flores-Rozas H; Soliman KF
Anticancer Res; 2017 Mar; 37(3):1205-1212. PubMed ID: 28314283
[TBL] [Abstract][Full Text] [Related]
9. LDH-A regulates the tumor microenvironment via HIF-signaling and modulates the immune response.
Serganova I; Cohen IJ; Vemuri K; Shindo M; Maeda M; Mane M; Moroz E; Khanin R; Satagopan J; Koutcher JA; Blasberg R
PLoS One; 2018; 13(9):e0203965. PubMed ID: 30248111
[TBL] [Abstract][Full Text] [Related]
10. WSB-1 regulates the metastatic potential of hormone receptor negative breast cancer.
Poujade FA; Mannion A; Brittain N; Theodosi A; Beeby E; Leszczynska KB; Hammond EM; Greenman J; Cawthorne C; Pires IM
Br J Cancer; 2018 May; 118(9):1229-1237. PubMed ID: 29540773
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth.
Zhao YH; Zhou M; Liu H; Ding Y; Khong HT; Yu D; Fodstad O; Tan M
Oncogene; 2009 Oct; 28(42):3689-701. PubMed ID: 19668225
[TBL] [Abstract][Full Text] [Related]
12. Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence.
Miyoshi Y; Shien T; Ogiya A; Ishida N; Yamazaki K; Horii R; Horimoto Y; Masuda N; Yasojima H; Inao T; Osako T; Takahashi M; Tomioka N; Endo Y; Hosoda M; Doihara H; Miyoshi S; Yamashita H;
Breast Cancer Res; 2016 Jul; 18(1):73. PubMed ID: 27368476
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous siRNA targeting of Src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line.
Bjorge JD; Pang AS; Funnell M; Chen KY; Diaz R; Magliocco AM; Fujita DJ
PLoS One; 2011 Apr; 6(4):e19309. PubMed ID: 21541295
[TBL] [Abstract][Full Text] [Related]
14. Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers.
Chiu JH; Wen CS; Wang JY; Hsu CY; Tsai YF; Hung SC; Tseng LM; Shyr YM
J Transl Med; 2017 May; 15(1):97. PubMed ID: 28472954
[TBL] [Abstract][Full Text] [Related]
15. The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer.
Xiao X; Huang X; Ye F; Chen B; Song C; Wen J; Zhang Z; Zheng G; Tang H; Xie X
Sci Rep; 2016 Feb; 6():21735. PubMed ID: 26902416
[TBL] [Abstract][Full Text] [Related]
16. Phosphoproteomic Analysis Identifies Focal Adhesion Kinase 2 (FAK2) as a Potential Therapeutic Target for Tamoxifen Resistance in Breast Cancer.
Wu X; Zahari MS; Renuse S; Nirujogi RS; Kim MS; Manda SS; Stearns V; Gabrielson E; Sukumar S; Pandey A
Mol Cell Proteomics; 2015 Nov; 14(11):2887-900. PubMed ID: 26330541
[TBL] [Abstract][Full Text] [Related]
17. PPFIA1 is upregulated in liver metastasis of breast cancer and is a potential poor prognostic indicator of metastatic relapse.
Yang J; Wu NN; Huang DJ; Luo YC; Huang JZ; He HY; Lu HL; Song WL
Tumour Biol; 2017 Jul; 39(7):1010428317713492. PubMed ID: 28720060
[TBL] [Abstract][Full Text] [Related]
18. Quantitative proteomics of primary tumors with varying metastatic capabilities using stable isotope-labeled proteins of multiple histogenic origins.
Lund RR; Terp MG; Laenkholm AV; Jensen ON; Leth-Larsen R; Ditzel HJ
Proteomics; 2012 Jul; 12(13):2139-48. PubMed ID: 22623409
[TBL] [Abstract][Full Text] [Related]
19. HER2-Driven Breast Tumorigenesis Relies upon Interactions of the Estrogen Receptor with Coactivator MED1.
Yang Y; Leonard M; Zhang Y; Zhao D; Mahmoud C; Khan S; Wang J; Lower EE; Zhang X
Cancer Res; 2018 Jan; 78(2):422-435. PubMed ID: 29187405
[TBL] [Abstract][Full Text] [Related]
20. TGFβ-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells.
Cesi V; Casciati A; Sesti F; Tanno B; Calabretta B; Raschellà G
Cell Cycle; 2011 Dec; 10(23):4149-61. PubMed ID: 22101269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
